stomach cramps after semaglutide injection Wegovy Pain: Causes, Relief, and When to Worry Side Effects of Wegovy Explained

Shares in Novo Nordisk were lifted by the announcement, raising its market cap above $315 billion, as investors responded to the building evidence base for semaglutide that seems to extend well beyond its initial applications in treating diabetes and obesity

SGLT2 inhibitors, but not GLP-1 receptor agonists, reduce incidence of gout in people living with type 2 diabetes across the therapeutic spectrum

Tirzepatide can significantly reduce appetite and cravings, making it easier to stick with healthier eating patterns over the long term

Heres what the research and my clinical experience reveal: Semaglutide is a well-established option with: Weekly injections Proven safety profile Average weight loss of 15-20% of body weight Effective appetite suppression Improvements in cardiovascular health markers Tirzepatide offers: Weekly injections Potentially greater weight loss (16-22.5% of body weight) Dual-action mechanism Similar side effect profile to semaglutide Enhanced metabolic benefits In a recent head-to-head trial , tirzepatide demonstrated superior weight loss compared to semaglutide, with participants losing an average of 20.2% versus 13.7% of their body weight at 72 weeks

These practices help ensure the medications are safe and effective, allowing for timely adjustments and interventions when necessary